Fast Five Quiz: Myelodysplastic Syndrome Pathology

Emmanuel C. Besa, MD

Disclosures

May 12, 2021

MDS-EB, previously called refractory anemia with excess blasts, is an MDS entity characterized by increased myeloblasts in the bone marrow and/or blood or the presence of Auer rods. Irrespective of blast count, the presence of Auer rods is associated with a poor survival and a high risk of transformation to AML. Their presence also excludes a diagnosis of MDS-MLD.

The presence of either 5%-9% blasts in the bone marrow (with < 5% blasts in the blood and absence of Auer rods) or 2%-4% blasts in the blood (with < 10% blasts in the bone marrow and absence of Auer rods) classifies as MDS-EB1. The presence of 10%-19% blasts in the bone marrow, 5%-19% blasts in the blood, or the presence of Auer rods classifies as MDS-EB2.

Learn more about MDS with excess blasts.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....